Fibrillin 1 (FBN1)

Fibrillin-1 is a major component of the microfibrils that form a sheath surrounding the amorphous elastin. It is believed that the microfibrils are composed of end-to-end polymers of fibrillin. To date, 3 forms of fibrillin have been described. The fibrillin-1 protein was isolated by Engvall in 1986, and mutations in the gene have been linked to the Marfan syndrome. At present more than 100 different mutations have been described. Trask et al. (1999) found that human FIB1 and FIB2 homodimerized via an N-terminal region and that the interaction was stabilized by disulphide bonds. Dimer formation occurred intracellularly, suggesting that the process of fibrillin aggregation initiates early after biosynthesis of the molecules.

Asprosin is generated from the gene FBN1 (amino acid residues 2732–2871), which also generates fibrillin.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA593Hu01 Recombinant Fibrillin 1 (FBN1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA593Hu02 Recombinant Fibrillin 1 (FBN1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA593Hu05 Recombinant Fibrillin 1 (FBN1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA593Hu03 Recombinant Fibrillin 1 (FBN1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA593Hu04 Recombinant Fibrillin 1 (FBN1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA593Hu06 Recombinant Fibrillin 1 (FBN1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA593Hu07 Recombinant Fibrillin 1 (FBN1) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA593Hu01 Polyclonal Antibody to Fibrillin 1 (FBN1) WB; ICC; IHC-P; IHC-F; ELISA.
MAA593Hu22 Monoclonal Antibody to Fibrillin 1 (FBN1) WB; IHC; ICC; IP.
PAA593Hu02 Polyclonal Antibody to Fibrillin 1 (FBN1) WB; ICC; IHC-P; IHC-F; ELISA.
LAA593Hu81 FITC-Linked Polyclonal Antibody to Fibrillin 1 (FBN1) WB; IHC; ICC; IF.
LAA593Hu71 Biotin-Linked Polyclonal Antibody to Fibrillin 1 (FBN1) WB; IHC; ICC.
PAA593Hu03 Polyclonal Antibody to Fibrillin 1 (FBN1) WB; ICC; IHC-P; IHC-F; ELISA.
PAA593Hu04 Polyclonal Antibody to Fibrillin 1 (FBN1) WB; ICC; IHC-P; IHC-F; ELISA.
PAA593Hu05 Polyclonal Antibody to Fibrillin 1 (FBN1) WB; IHC; ICC; IP.
PAA593Hu06 Polyclonal Antibody to Fibrillin 1 (FBN1) WB; IHC; ICC; IP.
Assay Kits SEA593Hu ELISA Kit for Fibrillin 1 (FBN1) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA593Hu CLIA Kit for Fibrillin 1 (FBN1) Chemiluminescent immunoassay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA593Mu02 Recombinant Fibrillin 1 (FBN1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA593Mu03 Recombinant Fibrillin 1 (FBN1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA593Mu01 Recombinant Fibrillin 1 (FBN1) Positive Control; Immunogen; SDS-PAGE; WB.
CPA593Mu21 OVA Conjugated Fibrillin 1 (FBN1) Immunogen; SDS-PAGE; WB.
APA593Mu01 Active Fibrillin 1 (FBN1) Cell culture; Activity Assays.
Antibodies PAA593Mu03 Polyclonal Antibody to Fibrillin 1 (FBN1) WB; ICC; IHC-P; IHC-F; ELISA.
PAA593Mu02 Polyclonal Antibody to Fibrillin 1 (FBN1) WB; ICC; IHC-P; IHC-F; ELISA.
PAA593Mu01 Polyclonal Antibody to Fibrillin 1 (FBN1) WB; IHC; ICC; IP.
LAA593Mu71 Biotin-Linked Polyclonal Antibody to Fibrillin 1 (FBN1) WB; IHC; ICC.
PAA593Mu08 Polyclonal Antibody to Fibrillin 1 (FBN1) WB; IHC; ICC; IP.
Assay Kits SEA593Mu ELISA Kit for Fibrillin 1 (FBN1) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA593Ra01 Recombinant Fibrillin 1 (FBN1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA593Ra02 Recombinant Fibrillin 1 (FBN1) Positive Control; Immunogen; SDS-PAGE; WB.
RPA593Ra03 Recombinant Fibrillin 1 (FBN1) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA593Ra01 Polyclonal Antibody to Fibrillin 1 (FBN1) WB; IHC; ICC; IP.
PAA593Ra02 Polyclonal Antibody to Fibrillin 1 (FBN1) WB; IHC; ICC; IP.
LAA593Ra71 Biotin-Linked Polyclonal Antibody to Fibrillin 1 (FBN1) WB; IHC; ICC.
PAA593Ra03 Polyclonal Antibody to Fibrillin 1 (FBN1) WB; IHC; ICC; IP.
Assay Kits SEA593Ra ELISA Kit for Fibrillin 1 (FBN1) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Bos taurus; Bovine (Cattle)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Fibrillin 1 (FBN1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Fibrillin 1 (FBN1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Fibrillin 1 (FBN1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Fibrillin 1 (FBN1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Fibrillin 1 (FBN1) ELISA Kit Customized Service Offer
  1. "Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome."Hum. Mol. Genet. 2:961-968(1993) [PubMed] [Europe PMC] [Abstract]
  2. "Three novel mutations of the fibrillin-1 gene and ten single nucleotide polymorphisms of the fibrillin-3 gene in Marfan syndrome patients."J. Hum. Genet. 49:404-407(2004) [PubMed] [Europe PMC] [Abstract]
  3. "Analysis of the DNA sequence and duplication history of human chromosome 15." Nature 440:671-675(2006) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  5. "Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5' end."Genomics 17:476-484(1993) [PubMed] [Europe PMC] [Abstract]
  6. "Partial sequence of a candidate gene for the Marfan syndrome."Nature 352:334-337(1991) [PubMed] [Europe PMC] [Abstract]
  7. "Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes."Nature 352:330-334(1991) [PubMed] [Europe PMC] [Abstract]
  8. "The skipping of constitutive exons in vivo induced by nonsense mutations."Science 259:680-683(1993) [PubMed] [Europe PMC] [Abstract]
  9. "Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils."J. Biol. Chem. 266:14763-14770(1991) [PubMed] [Europe PMC] [Abstract]
  10. "Molecular structure and interaction of recombinant human type XVI collagen."J. Mol. Biol. 339:835-853(2004) [PubMed] [Europe PMC] [Abstract]
  11. "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
  12. "ADAMTS10 protein interacts with fibrillin-1 and promotes its deposition in extracellular matrix of cultured fibroblasts."J. Biol. Chem. 286:17156-17167(2011) [PubMed] [Europe PMC] [Abstract]
  13. "ADAMTSL4, a secreted glycoprotein widely distributed in the eye, binds Fibrillin-1 microfibrils and accelerates microfibril biogenesis."Invest. Ophthalmol. Vis. Sci. 53:461-469(2012) [PubMed] [Europe PMC] [Abstract]
  14. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  15. "Solution structure of the transforming growth factor beta-binding protein-like module, a domain associated with matrix fibrils."EMBO J. 16:6659-6666(1997) [PubMed] [Europe PMC] [Abstract]
  16. "Calcium binding properties of an epidermal growth factor-like domain pair from human fibrillin-1."J. Mol. Biol. 255:22-27(1996) [PubMed] [Europe PMC] [Abstract]
  17. "Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders."Cell 85:597-605(1996) [PubMed] [Europe PMC] [Abstract]
  18. "Software and database for the analysis of mutations in the human FBN1 gene."Nucleic Acids Res. 24:137-141(1996) [PubMed] [Europe PMC] [Abstract]
  19. "Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene."Nucleic Acids Res. 25:147-150(1997) [PubMed] [Europe PMC] [Abstract]
  20. "Fibrillin-1 mutations in Marfan syndrome and other type-1 fibrillinopathies."Hum. Mutat. 10:415-423(1997) [PubMed] [Europe PMC] [Abstract]
  21. "The molecular genetics of Marfan syndrome and related microfibrillopathies."J. Med. Genet. 37:9-25(2000) [PubMed] [Europe PMC] [Abstract]
  22. "Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies."Hum. Mutat. 20:153-161(2002) [PubMed] [Europe PMC] [Abstract]
  23. "Association of mitral valve prolapse and systemic abnormalities of connective tissue: a phenotypic continuum."JAMA 262:523-528(1989) [PubMed] [Europe PMC] [Abstract]
  24. "Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization."Structure 12:717-729(2004) [PubMed] [Europe PMC] [Abstract]
  25. "Structure and interdomain interactions of a hybrid domain: a disulphide-rich module of the fibrillin/LTBP superfamily of matrix proteins."Structure 17:759-768(2009) [PubMed] [Europe PMC] [Abstract]
  26. "Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene."Nature 352:337-339(1991) [PubMed] [Europe PMC] [Abstract]
  27. "Clustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains."Hum. Mutat. 1:366-374(1992) [PubMed] [Europe PMC] [Abstract]
  28. "Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene."J. Clin. Invest. 89:1674-1680(1992) [PubMed] [Europe PMC] [Abstract]
  29. "Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome."Genomics 17:468-475(1993) [PubMed] [Europe PMC] [Abstract]
  30. "A novel fibrillin mutation in the Marfan syndrome which could disrupt calcium binding of the epidermal growth factor-like module."Hum. Mol. Genet. 2:475-477(1993) [PubMed] [Europe PMC] [Abstract]
  31. "Mutation screening of complete fibrillin-1 coding sequence: report of five new mutations, including two in 8-cysteine domains."Hum. Mol. Genet. 2:1813-1821(1993) [PubMed] [Europe PMC] [Abstract]
  32. "A compound-heterozygous Marfan patient: two defective fibrillin alleles result in a lethal phenotype."Am. J. Hum. Genet. 55:1083-1091(1994) [PubMed] [Europe PMC] [Abstract]
  33. "A novel mutation of the fibrillin gene causing ectopia lentis."Genomics 19:573-576(1994) [PubMed] [Europe PMC] [Abstract]
  34. "Two novel mutations and a neutral polymorphism in EGF-like domains of the fibrillin gene (FBN1): SSCP screening of exons 15-21 in Marfan syndrome patients."Hum. Mol. Genet. 3:373-375(1994) [PubMed] [Europe PMC] [Abstract]
  35. "An extra cysteine in one of the non-calcium-binding epidermal growth factor-like motifs of the FBN1 polypeptide is connected to a novel variant of Marfan syndrome."J. Clin. Invest. 94:709-713(1994) [PubMed] [Europe PMC] [Abstract]
  36. "A new missense mutation of fibrillin in a patient with Marfan syndrome."J. Med. Genet. 31:338-339(1994) [PubMed] [Europe PMC] [Abstract]
  37. "A novel mutation in the fibrillin gene (FBN1) in familial arachnodactyly."Mol. Cell. Probes 8:325-327(1994) [PubMed] [Europe PMC] [Abstract]
  38. "Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome."Nat. Genet. 6:64-69(1994) [PubMed] [Europe PMC] [Abstract]
  39. "A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection."Am. J. Hum. Genet. 56:1287-1296(1995) [PubMed] [Europe PMC] [Abstract]
  40. "Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons."Am. J. Hum. Genet. 57:8-21(1995) [PubMed] [Europe PMC] [Abstract]
  41. "The phenotypic continuum associated with FBN1 mutations includes the Shprintzen-Goldberg syndrome."Am. J. Hum. Genet. 57:A211-A211(1995)
  42. "A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome."J. Clin. Invest. 95:2373-2378(1995) [PubMed] [Europe PMC] [Abstract]
  43. "Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene."Am. J. Med. Genet. 62:233-242(1996) [PubMed] [Europe PMC] [Abstract]
  44. "Characterisation of four novel fibrillin-1 (FBN1) mutations in Marfan syndrome."J. Med. Genet. 33:665-671(1996) [PubMed] [Europe PMC] [Abstract]
  45. "A novel de novo mutation in exon 14 of the fibrillin-1 gene associated with delayed secretion of fibrillin in a patient with a mild Marfan phenotype."Hum. Genet. 100:195-200(1997) [PubMed] [Europe PMC] [Abstract]
  46. "The pathogenicity of the Pro1148Ala substitution in the FBN1 gene: causing or predisposing to Marfan syndrome and aortic aneurysm, or clinically innocent?"Hum. Genet. 99:607-611(1997) [PubMed] [Europe PMC] [Abstract]
  47. "Mutation screening of all 65 exons of the fibrillin-1 gene in 60 patients with Marfan syndrome: report of 12 novel mutations."Hum. Mutat. 10:280-289(1997) [PubMed] [Europe PMC] [Abstract]
  48. "P1148A in fibrillin-1 is not a mutation leading to Shprintzen-Goldberg syndrome."Hum. Mutat. 10:326-327(1997) [PubMed] [Europe PMC] [Abstract]
  49. "P1148A in fibrillin-1 is not a mutation anymore."Nat. Genet. 15:12-12(1997) [PubMed] [Europe PMC] [Abstract]
  50. "Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome."Am. J. Hum. Genet. 63:1703-1711(1998) [PubMed] [Europe PMC] [Abstract]
  51. "Correlation of a recurrent FBN1 mutation (R122C) with an atypical familial Marfan syndrome phenotype."Hum. Mutat. Suppl. 1:S198-S200(1998) [PubMed] [Europe PMC] [Abstract]
  52. "A novel mutation in the neonatal region of the fibrillin (FBN) 1 gene associated with a classical phenotype of Marfan syndrome (MfS)."Hum. Mutat. 12:137-137(1998) [PubMed] [Europe PMC] [Abstract]
  53. "Demonstration of the recurrence of Marfan-like skeletal and cardiovascular manifestations due to germline mosaicism for an FBN1 mutation."Am. J. Hum. Genet. 65:917-921(1999) [PubMed] [Europe PMC] [Abstract]
  54. "Identification of 9 novel FBN1 mutations in German patients with Marfan syndrome."Hum. Mutat. 14:181-181(1999) [PubMed] [Europe PMC] [Abstract]
  55. "Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome."Arch. Intern. Med. 161:2447-2454(2001) [PubMed] [Europe PMC] [Abstract]
  56. "TGGE screening of the entire FBN1 coding sequence in 126 individuals with Marfan syndrome and related fibrillinopathies."Hum. Mutat. 20:197-208(2002) [PubMed] [Europe PMC] [Abstract]
  57. "Sensitivity of conformation sensitive gel electrophoresis in detecting mutations in Marfan syndrome and related conditions."J. Med. Genet. 39:34-41(2002) [PubMed] [Europe PMC] [Abstract]
  58. "In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome."J. Med. Genet. 40:34-36(2003) [PubMed] [Europe PMC] [Abstract]
  59. "Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy."Hum. Mutat. 23:99-99(2004) [PubMed] [Europe PMC] [Abstract]
  60. "Consequences of cysteine mutations in calcium-binding epidermal growth factor modules of fibrillin-1."J. Biol. Chem. 279:32924-32931(2004) [PubMed] [Europe PMC] [Abstract]
  61. "Identification of sixty-two novel and twelve known FBN1 mutations in eighty-one unrelated probands with Marfan syndrome and other fibrillinopathies." Hum. Mutat. 26:494-494(2005) [PubMed] [Europe PMC] [Abstract]
  62. "Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome."Hum. Mutat. 26:529-539(2005) [PubMed] [Europe PMC] [Abstract]
  63. "Central nervous system abnormalities in two cases with neonatal Marfan syndrome with novel mutations in the fibrillin-1 gene."Am. J. Med. Genet. A 152:2409-2412(2010) [PubMed] [Europe PMC] [Abstract]
  64. "A Japanese-specific allele in the GALNT11 gene."Leg. Med. 12:208-211(2010) [PubMed] [Europe PMC] [Abstract]
  65. "Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome."Sci. Transl. Med. 2:23RA20-23RA20(2010) [PubMed] [Europe PMC] [Abstract]
  66. "Mutations in the TGFbeta binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias." Am. J. Hum. Genet. 89:7-14(2011) [PubMed] [Europe PMC] [Abstract]
  67. "Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys-Dietz syndromes."Hum. Mutat. 32:1053-1062(2011) [PubMed] [Europe PMC] [Abstract]